Published on October 17, 2014
slide 1: House Dust Mite Allergy – Pipeline Review H2 2014 © RnRMarketResearch.com salesrnrmarketresearch.com +1 888 391 5441 Single User License : US 2000 Corporate User License : US 6000 Order this report by calling +1 888 391 5441 or Send an email to salesrnrmarketresearch.com with your contact details and questions if any. slide 2: House Dust Mite Allergy – Pipeline Review H2 2014 Summary Researcher’s House Dust Mite Allergy Pipeline Review H2 2014′ provides an overview of the House Dust Mite Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for House Dust Mite Allergy complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action MoA route of administration RoA and molecule type along with latest updates and featured news and press releases. It also reviews key players involved in the therapeutic development for House Dust Mite Allergy and special features on late-stage and discontinued projects. © RnRMarketResearch.com salesrnrmarketresearch.com +1 888 391 5441 slide 3: House Dust Mite Allergy – Pipeline Review H2 2014 Researcher’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3000 indications. The report is built using data and information sourced from Researcher’s proprietary databases Company/University websites SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources put together by Researcher’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally processes including live news deals tracking browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. © RnRMarketResearch.com salesrnrmarketresearch.com +1 888 391 5441 slide 4: House Dust Mite Allergy – Pipeline Review H2 2014 Scope The report provides a snapshot of the global therapeutic landscape of House Dust Mite Allergy The report reviews key pipeline products under drug profile section which includes product description MoA and RD brief licensing and collaboration details other developmental activities The report reviews key players involved in the therapeutics development for House Dust Mite Allergy and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects Complete report is available http://www.rnrmarketresearch.com/house- dust-mite-allergy-pipeline-review-h2-2014-market-report.html . © RnRMarketResearch.com salesrnrmarketresearch.com +1 888 391 5441 slide 5: House Dust Mite Allergy – Pipeline Review H2 2014 Reasons to Buy Provides strategically significant competitor information analysis and insights to formulate effective RD development strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for House Dust Mite Allergy Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Buy a copy of this report http://www.rnrmarketresearch.com/contacts/purchasername214148 . © RnRMarketResearch.com salesrnrmarketresearch.com +1 888 391 5441 slide 6: House Dust Mite Allergy – Pipeline Review H2 2014 For more details contact Mr. Ritesh Tiwari: salesrnrmarketresearch.com / +18883915441 © RnRMarketResearch.com salesrnrmarketresearch.com +1 888 391 5441 RnR Market Research RnRMarketResearch.com an online repository of market research reports offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe.